Nolan Townsend is the founder of LEXEO Therapeutics. Latest round: Growth. Based in New York, NY.
R. Nolan Townsend is the Co-founder and CEO of LEXEO Therapeutics, a clinical-stage genetic medicine company focused on treating genetically-defined cardiovascular diseases and APOE4-associated Alzheimer's disease. He has led the company since January 2020, guiding its development of pioneering gene therapies and precision medicine approaches. Townsend co-founded LEXEO in 2020 alongside Ronald Crystal, MD.
Full founder directory · Investor directory · Company funding database · Fundraising library